Perrigo Ordinary Shares reported $119M in EBITDA for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbott ABT:US $ 2366M 678M
Aphria Inc APH:CN C$ -69699000 38.32M
Bayer BAYN:GR € 3035M 1119M
Bristol Myers Squibb BMY:US $ 5679M 455M
Catalent CTLT:US $ 326.3M 57.5M
Coherus Biosciences CHRS:US $ -23.29M 143.22M
Corcept Therapeutics CORT:US $ 32.2M 12.31M
Dr.Reddys Laboratories DRRD:IN IR 9183M 1364M
Eli Lilly And LLY:US $ 1797.7M 218.8M
Endo International Ordinary Shares ENDP:US $ 314.75M 18.87M
Flexion Therapeutics FLXN:US $ -16357000 6.26M
Gw Pharmaceuticals GWPH:US $ -17.18M 2.02M
Horizon Pharma HZNP:US $ 305.69M 324.32M
JAZZ PHA JAZZ:US $ 77.72M 157.36M
Johnson & Johnson JNJ:US $ 8103M 786M
Lannett LCI:US $ 4.57M 7.98M
Pacira Pharmaceuticals PCRX:US $ 39.89M 13.68M
Perrigo Ordinary Shares PRGO:US $ 119M 18.5M
Pfizer PFE:US $ 7593M 610M
Phibro Animal Health PAHC:US $ 27M 1.05M
Prestige Brands PBH:US $ 98.94M 20.46M
Supernus Pharmaceuticals SUPN:US $ 40.06M 20.24M
Teva Pharmaceutical TEVA:IT 1.14B 34M
Xeris Pharmaceuticals Inc XERS:US $ -25467000 9.06M
Zoetis ZTS:US $ 838M 30M